hims & hers glp-1 swings to a loss in Q1 amid shift in strategy Hims & Hers: The Risks

[DOI] [PubMed] [Google Scholar] 122.Quitadamo P., Zenzeri L., Mozzillo E., Giorgio V., Rocco A., Franzese A., Nardone G., Staiano A

This once-weekly injection is effective for individuals with a BMI of 30 or higher, or 27 and above with comorbid conditions

La eleccin del GLP-1 debe individualizarse considerando indicacin primaria, comorbilidades cardiovasculares y tolerabilidad

Unanswered Mechanistic and Clinical Questions Despite extensive research, the precise mechanisms driving all the cardiovascular benefits remain partially unresolved

If certified, the case could test how courts evaluate marketing language for compounded medications and the extent to which telehealth platforms must distinguish between FDA-approved drugs and compounded alternatives

It appears safe to continue these medications before a procedure requiring anaesthesia or sedation, with minor precautions like abstaining from solid food for a day to minimize any potential risk of aspiration. Recent reports and studies suggest that taking GLP-1 medications is associated with slower digestion with a larger amount of food remaining in the stomach